Atlas Trials

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

Clinical trial NCT00496873 · COMPLETED

Trial details

NCT number
NCT00496873
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-06-01
Primary completion
2014-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.